1972
DOI: 10.1002/art.1780150317
|View full text |Cite
|
Sign up to set email alerts
|

Lactoferrin in synovial fluid of patients with inflammatory arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

1973
1973
2016
2016

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 4 publications
0
6
0
Order By: Relevance
“…The contribution of plasma lysozyme to the SF values is unlikely to be significant because its plasma level is relatively low: -1.5 pg/ml (29). Because lactoferrin is not found in cartilage (25) or synovial membrane (21,24), and because it has recently been shown to be localized only to neutrophils in the peripheral blood (23), its level in synovial fluid can be taken as an index of neutrophil lysosomal activation. This application of the lactoferrin level was experimentally validated in the present study by its isochronous release with lysozyme and P-glucuronidase from phagocytosing human neutrophils ( Figure I).…”
Section: Discussionmentioning
confidence: 99%
“…The contribution of plasma lysozyme to the SF values is unlikely to be significant because its plasma level is relatively low: -1.5 pg/ml (29). Because lactoferrin is not found in cartilage (25) or synovial membrane (21,24), and because it has recently been shown to be localized only to neutrophils in the peripheral blood (23), its level in synovial fluid can be taken as an index of neutrophil lysosomal activation. This application of the lactoferrin level was experimentally validated in the present study by its isochronous release with lysozyme and P-glucuronidase from phagocytosing human neutrophils ( Figure I).…”
Section: Discussionmentioning
confidence: 99%
“…In addition to the antimicrobial properties, Lf ability to modulate the overall immune response and to protect against viral infections and septic shock have been largely described (Legrand et al 2005;Valenti and Antonini 2005;Ward et al 2002). In this respect, it is noteworthy that Lf concentrations are elevated locally in inflammatory disorders including neurodegenerative diseases (Kawamata et al 1993), inflammatory bowel disease (Uchida et al 1994), arthritis (Decoteau et al 1972), and allergic inflammation (van de Graaf et al 1991). Although the cellular and molecular mechanisms accounting for the immunomodulatory effects of Lf are far from being fully elucidated, both in vitro and in vivo studies suggest the existence of multiple mechanisms that include modulation of cytokine/ chemokine production, regulation of reactive oxygen species production, and of immune cell recruitment.…”
Section: Introductionmentioning
confidence: 93%
“…However, it has multifunctional activities ranging from the intestinal iron absorption, intestinal cell growth augmentation, regulation of myelopoiesis and immune responses (Kanwar et al, 2008). Lf also has a defensive role in the body as its levels were found to be profoundly elevated in the pathological conditions such as the neurodegeneration (Leveugle et al, 1994), inflammatory diseases (Uchida et al, 1994), asthma and arthritis (Decoteau et al, 1972). In addition to this, bovine Lf (bLf) also exhibited potent anti‐cancer activities in the xenograft mice model including the inhibition of tumour metastasis (Kanwar et al, 2008).…”
Section: Introductionmentioning
confidence: 99%